Affiliation:
1. Department of Pharmacy Practice, University of Illinois, Chicago 60612.
Abstract
Metronidazole is metabolized to two major oxidative products: an acid metabolite and a hydroxy metabolite. While the activity of the acid metabolite is negligible, the activity of the hydroxy metabolite is approximately 65% of the activity of the parent drug. Pharmacokinetic studies of metronidazole and its hydroxy metabolite have shown that the MICs of both compounds remain above the MICs for most anaerobic organisms over an 8-h dosing interval. By a checkerboard assay, the combined activities of metronidazole and the hydroxy metabolite were examined against 4 quality control strains of Bacteroides species. Macrobroth tube dilutions were set up with Wilkins-Chalgren broth. Serial twofold dilutions of each agent were performed to achieve final concentrations ranging from 0.06 to 4.0 micrograms/ml. The MICs for Bacteroides fragilis and B. distasonis were 1.0 microgram/ml for both parent drug and metabolite. For B. thetaiotamicron and B. ovatus, the MICs of metronidazole and the hydroxy metabolite were 1.0 and 2.0 micrograms/ml, respectively. Synergy was determined by calculating the fractional inhibitory concentration (FIC) index. The interpretative criteria for the FIC index were as follows: synergy, FIC < or = 0.5; partial synergy, 0.51 to 0.75; indifference, FIC 0.76 to 4.0; and antagonism, FIC > 4.0. Partial synergy was observed for the four anaerobes tested, with FIC indices ranging from 0.63 to 0.75. On the basis of this data, in vitro susceptibilities to agents such as metronidazole may ultimately require reevaluation to account for active metabolites.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference32 articles.
1. American Society for Microbiology. 1993. Instructions to authors. Antimicrob. Agents Chemother. 37:i-xiii.
2. Intravenous metronidazole in the treatment of abdominal sepsis: once vs three times daily administration;Auger P.;Curr. Ther. Res.,1988
3. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents;Betriu C.;Antimicrob. Agents Chemother.,1990
4. Susceptibility of anaerobic bacteria to antimicrobial agents;Collignon P. J.;Pathology,1988
5. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States;Cornick N. A.;J. Antimicrob. Chemother.,1990
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献